skip to main content

H.R. 6143: Patient Right to Know Drug Prices Act

Call or Write Congress

To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees.

The bill’s titles are written by its sponsor.

Sponsor and status

Lloyd Doggett

Sponsor. Representative for Texas's 35th congressional district. Democrat.

Read Text »
Last Updated: Jun 19, 2018
Length: 3 pages
Introduced:

Jun 19, 2018

Status:

Enacted Via Other Measures

Provisions of this bill were incorporated into other bills which were enacted, so there will not likely be further activity on this bill.

Prognosis:

2% chance of being enacted according to Skopos Labs (details)

See Instead:

S. 2554 (same title)
Enacted — Signed by the President — Oct 10, 2018

History

Jun 19, 2018
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

H.R. 6143 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 6143 — 115th Congress: Patient Right to Know Drug Prices Act.” www.GovTrack.us. 2018. November 16, 2018 <https://www.govtrack.us/congress/bills/115/hr6143>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.